These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9187525)

  • 41. Safety and efficacy: the role of chemistry, manufacturing, and controls in pharmaceutical drug development.
    DiFeo TJ
    Drug Dev Ind Pharm; 2004 Mar; 30(3):247-57. PubMed ID: 15109024
    [No Abstract]   [Full Text] [Related]  

  • 42. What can the use of unmetabolizable lipophilic compounds tell about the importance of drug metabolism?
    Bickel MH
    Drug Metab Rev; 1989; 20(2-4):441-7. PubMed ID: 2509182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Drug permeation through artificial lipid membranes. 17. The mechanism of ion pair transport].
    Neubert R; Fürst W; Böhm W; Dabow S
    Pharmazie; 1984 Jun; 39(6):401-3. PubMed ID: 6091156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of "drugs for liver disease" on hepatotoxic action of carbon tetrachloride. IV. Relationship between fatty acid composition of phospholipids and drug monooxygenation activity in rat liver microsomes and role of phosphorylcholine.
    Ogiso T; Kuhara K; Kobayashi T; Masuda H; Kato Y
    Chem Pharm Bull (Tokyo); 1977 Jan; 25(1):87-95. PubMed ID: 852086
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent methodologies for the estimation of n-octanol/water partition coefficients and their use in the prediction of membrane transport properties of drugs.
    Klopman G; Zhu H
    Mini Rev Med Chem; 2005 Feb; 5(2):127-33. PubMed ID: 15720283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors affecting gastrointestinal absorption of drugs.
    Levine RR
    Am J Dig Dis; 1970 Feb; 15(2):171-88. PubMed ID: 4905589
    [No Abstract]   [Full Text] [Related]  

  • 47. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption.
    Clark DE
    J Pharm Sci; 1999 Aug; 88(8):807-14. PubMed ID: 10430547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absorption potential and its variants.
    Boxenbaum H
    Pharm Res; 1999 Dec; 16(12):1893. PubMed ID: 10644080
    [No Abstract]   [Full Text] [Related]  

  • 49. The interaction of intercalating drugs with nucleic acids.
    Berman HM; Young PR
    Annu Rev Biophys Bioeng; 1981; 10():87-114. PubMed ID: 7020585
    [No Abstract]   [Full Text] [Related]  

  • 50. [Drug metabolism and drug kinetics as basis for clinical testing of new drugs].
    Bickel MH
    Ther Umsch; 1971 Apr; 28(4):250-6. PubMed ID: 4930185
    [No Abstract]   [Full Text] [Related]  

  • 51. Physiological and physicochemical bases of drug interactions in man.
    Dayton PG; Perel JM
    Ann N Y Acad Sci; 1971 Jul; 179():67-87. PubMed ID: 4105795
    [No Abstract]   [Full Text] [Related]  

  • 52. Modulation of pharmacokinetics by modification of the various factors involved.
    Ariëns EJ
    Farmaco Sci; 1969 Jan; 24(1):3-102. PubMed ID: 4976633
    [No Abstract]   [Full Text] [Related]  

  • 53. Thixotropic property in pharmaceutical formulations.
    Lee CH; Moturi V; Lee Y
    J Control Release; 2009 Jun; 136(2):88-98. PubMed ID: 19250955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of polymers enabling nano-comminution of water-insoluble drugs.
    Lee J; Choi JY; Park CH
    Int J Pharm; 2008 May; 355(1-2):328-36. PubMed ID: 18261866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.
    Fahr A; van Hoogevest P; May S; Bergstrand N; S Leigh ML
    Eur J Pharm Sci; 2005 Nov; 26(3-4):251-65. PubMed ID: 16112849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parenteral microemulsions: an overview.
    Date AA; Nagarsenker MS
    Int J Pharm; 2008 May; 355(1-2):19-30. PubMed ID: 18295991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measurement of the renal clearance of drugs.
    Tucker GT
    Br J Clin Pharmacol; 1981 Dec; 12(6):761-70. PubMed ID: 7041933
    [No Abstract]   [Full Text] [Related]  

  • 58. A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientist.
    Wilson AG; Nouraldeen A; Gopinathan S
    Future Med Chem; 2010 Jan; 2(1):1-5. PubMed ID: 21426039
    [No Abstract]   [Full Text] [Related]  

  • 59. Time-related differences in the physical property profiles of oral drugs.
    Leeson PD; Davis AM
    J Med Chem; 2004 Dec; 47(25):6338-48. PubMed ID: 15566303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comments on "Solvatochromic linear solvation energy relationship in describing drug solubilities".
    Leggett DC
    J Pharm Sci; 1994 Jul; 83(7):1065. PubMed ID: 7965667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.